News

Follow Us

To stay abreast of the
latest developments at
our fast-moving company,
please follow us on
Twitter, LinkedIn, and
Facebook:

  • Silicon Biosystems Menarini, Swift Biosciences Announce Collaboration and Co-Marketing Partnership to Unlock Genomic Information from FFPE Samples

    Orlando, FL - Wednesday, February 10, 2016

    Silicon Biosystems and Swift Biosciences today announced a scientific collaboration and co-marketing partnership aimed at enabling translational researchers to obtain high-quality sequencing results from as few as a couple hundred tumor and normal cells in an optimized and seamless workflow.

    Read the full article
  • Sophia Genetics Partners with Swift Biosciences to Offer MDx Solution

    LAUSANNE, Switzerland and Ann Arbor, MI USA - Tuesday, February 9, 2016

    Sophia Genetics, the global leader in Data Driven Medicine (DDM), announces the launch of a new combined solution for molecular diagnostics in Europe, combining sample processing with data analysis.

    Read the full article
  • Swift Biosciences and SeraCare Partner on Circulating Tumor DNA Standards for NGS-Based Oncology Assays

    Ann Arbor, MI and Milford, MA - Wednesday, January 27, 2016

    Swift Biosciences, developer of innovative technologies for genomics research, and SeraCare Life Sciences, a manufacturer and leading partner to global in-vitro diagnostics manufacturers, have announced a partnership to accelerate development of a novel circulating tumor DNA reference material.

    Read the full article
  • Cancer Research UK Manchester Institute Uses Accel-NGS 2S Hyb Kit for Effective Library Preparation for NGS Analysis of Liquid Biopsies

    SelectScience - Friday, January 15, 2016

    Dr Mahmood Ayub, post-doctoral fellow in the Clinical and Experimental Pharmacology group at Cancer Research UK Manchester Institute, and working under the leadership of Caroline Dive and Ged Brady, uses liquid biopsies to study blood biomarkers present in circulating, cell-free DNA (cfDNA) originating from tumors.

    Read the full article
  • WashU, Baylor Genome Centers Speak on Whole Genome Sequencing Using Swift Kits at ASHG

    Baltimore, MD - Thursday, October 8, 2015

    At the ASHG 2015 annual meeting, Swift Biosciences hosted the Exhibitor Education Event "Improving Whole Human Genome Sequencing on Illumina® Platforms". This event featured Dr. Vince Magrini from the McDonnell Genome Center at Washington University in St. Louis speaking on "Rescuing precious FFPE samples from breast cancer tissue with new library preparation method" and Donna Muzny from the Human Genome Sequencing Center at Baylor College of Medicine speaking on "Swift library prep methods for enhanced NGS applications".

    Read the full article
  • Swift Biosciences and the Salk Institute Present Methyl-Seq Webinar

    Ann Arbor, MI - Thursday, October 1, 2015

    In conjunction with collaborators from the Salk Institute, Swift Biosciences presented the webinar "Lowering the Limits for Epigenetic Methylation Analysis" via GenomeWeb. This webinar discussed a new library preparation method that enables complete methylome characterization from only about 20 starting cells.

    Read the full article
  • NOAA, Swift Bio Scientists Partner to Create DNA Libraries of Endangered Vaquita Porpoise

    GenomeWeb - Wednesday, August 5, 2015

    As part of a larger conservation effort, researchers from the National Oceanic and Atmospheric Administration (NOAA) have collaborated with Swift Biosciences to create DNA libraries for the critically endangered vaquita porpoise (Phocoena sinus), a small porpoise species that can only be found in the northern Gulf of California.

    Read the full article
  • Fluxion Biosciences and Swift Biosciences Announce Jointly Developed Next-Generation Sequencing Workflow for Somatic Mutation Detection from Liquid Biopsy Samples

    Press Release - South San Francisco, CA - Wednesday, May 27, 2015

    In advance of the 2015 American Society of Clinical Oncology Annual meeting, Fluxion Biosciences, Inc. and Swift Biosciences, Inc. announced a new workflow for oncology clinical research designed to detect somatic mutations from a routine blood draw. The jointly-developed workflow utilizes Fluxion’s IsoFlux™ System for circulating tumor cell (CTC) enrichment and Swift’s Accel-Amplicon™ technology for high sensitivity variant detection using low starting inputs.

    Read the full article
  • Overcoming One of the Major Technical Limitations for Epigenetics Research

    Press Release - Ann Arbor, MI - Thursday, April 2, 2015

    Epigenetic researchers can now address one of the key limitations to current studies; the amount of starting material that is required to perform DNA sequencing of whole genome bisulfite converted samples. By reducing the amount of required starting material by over a hundredfold, Swift Biosciences, Inc., is enabling researchers to redefine their project designs as they can now use hundreds of cells to completely characterize the entire methylome, a critical element of genomic function and stability.

    Read the full article
  • Swift Biosciences Announces Early Access Program for Accel-Amplicon™ Panels

    Press Release - Ann Arbor, MI - Tuesday, November 11, 2014

    Swift Biosciences, Inc. today announced the launch of an early access program for Accel-Amplicon Panels for use with Illumina® Next Generation Sequencing (NGS) systems. The assays are compatible with FFPE and circulating cell free DNA from 10 ng of genomic DNA.

    Read the full article
  • Genome Sequence of Klebsiella pneumoniae Respiratory Isolate IA565 Published Using Accel-NGS® 2S DNA Library Kit

    Genome Announcements - Thursday, September 11, 2014

    Investigators at the University of Michigan and the University of Toledo have published the sequence of the K. pneumoniae strain IA565 using libraries prepared with the Accel-NGS® 2S DNA Library Kit for Illumina®.

    Read the full article
  • Genome Sequence of Klebsiella pneumoniae Urinary Tract Isolate Top52 Published Using Accel-NGS® 2S DNA Library Kit

    Genome Announcements - Thursday, July 3, 2014

    Investigators at the University of Michigan and the University of Toledo have published the sequence of the K. pneumoniae strain TOP52 #1721 using libraries prepared with the Accel-NGS® 2S DNA Library Kit for Illumina®.

    Read the full article
  • Swift Biosciences Launches Accel-NGS® 2S DNA Library Kit

    Press Release - Ann Arbor, MI - Monday, March 3, 2014

    Incorporating patent-pending technology, the Swift “2S” kit provides linear yields from inputs ranging from 10 pg to 1 µg. PCR-free libraries can be produced from as little as 100 ng. Unlike other commercially available kits, exceptional quality and evenness of coverage are obtained even at very low levels of DNA input. The product is also ideally suited for clinical samples such as FFPE tissues and plasma.

    Read the full article
  • Genome Sequences of C. jejuni Variants Published Using Accel-NGS® DNA Library Kit for Ion Torrent™

    Genome Announcements - Thursday, February 6, 2014

    Investigators at the University of Michigan have published the sequences of three C. jejuni strains using libraries prepared with the Accel-NGS® DNA Library Kit for Ion Torrent™.

    Read the full article
  • Swift Biosciences, Inc. Announces the Launch of Accel-NGS® PCR-free DNA Library Kit for Illumina®

    Press Release - Ann Arbor, MI - Monday, November 11, 2013

    Swift Biosciences, Inc. today announced the launch of the Accel-NGS® PCR-free DNA Library Kit for Illumina® Next Generation Sequencing (NGS) systems. This launch follows the successful launch earlier this year of a similar product for use on Ion Torrent platforms. Swift's new kit is designed to bring the same benefits - low input requirement, PCR-free capability and fast, easy workflow - to the Illumina platform.

    Read the full article
  • Swift Biosciences Announces $7 Million Series B Financing

    Press Release - Ann Arbor, MI - Thursday, October 17, 2013

    Swift Biosciences, Inc., a Michigan-based life sciences company, today announced the recent completion of a $7 million Series B financing led by Fletcher Spaght Ventures. Also joining in the B round of investment was Renaissance Venture Capital Fund and the Series A investors, including the Mercury Fund, Michigan Accelerator Fund and several Michigan-based individual investors.

    Read the full article
  • Swift Biosciences Announces Early Access Program for Accel-NGS® DNA Library Kit for Illumina®

    Press Release - Ann Arbor, MI - Wednesday, June 26, 2013

    Swift Biosciences, Inc. today announced an Early Access Program for the Accel-NGS® DNA Library Kit for Illumina® Next Generation Sequencing (NGS) systems.

    Read the full article
  • Swift Biosciences Introduces Accel-NGS® DNA Library Kit

    Press Release - Ann Arbor, MI - Wednesday, February 27, 2013

    Swift Biosciences, Inc. today announced the launch of the Accel-NGS® DNA Library Kit, the first product in a new line of kits for Next Generation Sequencing (NGS) sample preparation. NGS users can now produce PCR-free libraries with as little as 5 ng of input DNA.

    Read the full article